Sriram Yennu

Sriram Yennu is a Professor and Director at The University of Texas MD Anderson Cancer Center, where he specializes in palliative care, symptom management, and supportive oncology. His research focuses on pharmacological and behavioral interventions for cancer-related fatigue, including randomized trials of dexamethasone, methylphenidate, and physical activity, as well as the placebo effect in fatigue treatment trials. He has led international initiatives, such as the Extension for Community Healthcare Outcomes-Palliative Care program in Africa, examining quality of life and caregiver distress. Yennu co-authored the 2024 ASCO–Society for Integrative Oncology guideline update on fatigue management and has secured major grants, including a $691,000 award for multimodal fatigue therapy. His recent work also addresses insomnia interventions and symptom control in advanced cancer.